Clinical trial
Ferumoxytol-enhanced Imaging and Quantitative Susceptibility Mapping in neuroAIDS
NCT02678767 is registered in ClinicalTrials.gov with Beau Nakamoto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ferumoxytol-enhanced Imaging and Quantitative Susceptibility Mapping in neuroAIDS
- Lead sponsor
- Beau Nakamoto
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- September 30, 2017
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.